This course type is lecture

Practical Aspects of Small Molecule Drug Discovery: At the Interface of Biology, Chemistry and Pharmacology

20 - 25 June 2021Wellcome Genome Campus, UK
Deadlines (at 23:59 UTC):
  • Application and bursary deadline 18 March 2021
Apply

A broad introduction to the theoretical, practical and organisational aspects of small molecule drug discovery

  • Summary

    Please note: This course was cancelled in 2020 due to the Covid-19 pandemic. Applications for the 2020 course have been carried over to 2021. The course is now open to new applicants.

    Many scientists across diverse disciplines in research institutions and small and medium-sized companies are expanding into early-stage drug discovery. However, this transition requires successfully combining multiple disciplines including biochemistry, medicinal and computational chemistry, pharmacokinetics, pharmacology and project management, the breadth of which can present organisational, knowledge and competence challenges for institutions and investigators.

    This popular, biennial, lecture- and discussion-based course is highly interactive and gives scientists of all disciplines a broad introduction to the theoretical, practical and organisational aspects of small molecule drug discovery.

    Each topic-based lecture mixes presentation with discussion sessions and case histories to develop the key aspects highlighted in the talk and to illustrate how each participant and their discipline fits into the complex journey of a drug discovery project. Additional discussion-based practical sessions build on the lectures to illustrate the strategic planning of drug discovery programmes, including the development of target product profiles, compound progression criteria and scientific strategy.

  • Programme

    The interactive programme will include lectures and discussions covering the following topics:

    • Project management and organisation of multi-disciplinary projects
    • Target selection and validation
    • Hit discovery options, assay development and quality control
    • Fragment-based drug discovery
    • Natural product based drug discovery
    • Mode of action elucidation of phenotypic hits
    • Screening set selection, storage and quality control
    • Data mining
    • Introduction to pharmacokinetics
    • Principles of compound optimisation and case histories
    • In silico approaches to drug design
    • Intellectual property strategy
    • An introduction to preclinical and clinical development

     

    Learning Outcomes
    After attending the course, participants will be able to:

    • Describe the overall drug discovery process and its relationship to the participants’ specific disciplines.
    • Explain the major technical aspects of the drug discovery process, starting with target selection to compound screening to designing lead candidates
    • Describe and evaluate current modern drug discovery concepts (which attempt to identify high quality drug candidates) using either a target-based or phenotypic approach to tackle the related disease
    • Compare multiple drug discovery tools and methods used for finding, identifying and designing a new drug
    • Identify the pre-clinical steps to gain assurance that it is safe and appropriate to initiate clinical evaluation of the candidate
    • Assess and evaluate the processes, chemistry and formulation aspects which impact on early drug development
    • Explain the clinical development process
    • Recognise the commercial importance of intellectual property
  • Instructors and speakers

    Course organisers

    Paul Wyatt

    Paul Wyatt
    Director of the Wellcome Centre for Anti-Infectives Research, University of Dundee, UK

    Claire Thompson

    Claire Thompson
    Agility Health Tech, UK

    David Gray

    David Gray
    Head of Biology, Drug Discovery Unit, University of Dundee, UK

    Guest speakers

    Each year, the course is presented by a prestigious panel of guest lecturers recruited from industry, academia and leading not-for-profit organisations. Guest lecturers in previous years have included senior representatives with experience of working for multiple major Pharma, Biotech and Contract Research companies, including:

    • Pfizer
    • GlaxoSmithKline
    • AstraZeneca
    • Astex Pharmaceuticals
    • Charles River Laboratories
    • 
European Bioinformatics Institute
    • LifeArc
    • University of Dundee
    • EMBL-EBI
    • Albany Regulatory Consulting Limited
    • Imperial College
    • ProPharma Partners Limited
    • Mission Therapeutics
  • Cost and bursaries
    Cost Accommodation / meals
    *Course fee £750 This is a residential course and the fee includes all on-site accommodation and meals.

    The course fee is subsidised by Wellcome Genome Campus Advanced Courses and Scientific Conferences.

    Bursaries
    Limited bursaries are available (up to 50% reduction on the course fee) and are awarded on merit. If you would like to apply for a bursary, please complete the bursary section of the online application form.

    Where there are many bursary applications, the selection committee may issue smaller amounts.

    Bursaries can be applied for as part of the course application form. Applicants will be notified of a bursary award along with their place on the course, usually within one month of the application deadline. The decision of the selection committee is final.

    Please note that both the applicant and sponsor are required to provide a justification for the bursary as part of the application.

    Additional funding opportunities
    Visit our support page for additional financial support currently available.


    Accommodation services phishing scam – please be vigilant. More information.

  • How to apply

    Prerequisites
    Applications are invited from academic or commercial backgrounds in
    relevant fields, e.g:

    • New postdoctoral recruits to already established facilities
    • Postdoctoral grade researchers in small or medium sized companies
    • Senior investigators considering entering the field
    • Recipients, and their staff, of Seeding Drug Discovery project funding
    • Established investigators seeking further professional development

     

    How to Apply
    Please click the Apply button above to begin the online application process. Places are limited and will be awarded on merit. If you have any problems with the online application process, please contact us.

    Please note: Applications must be supported by a recommendation from a scientific or clinical sponsor (e.g. supervisor, line manager or head of department). A request for a supporting statement will be sent to your nominated sponsor automatically during the application process. Applicants must ensure that their sponsor provides this supporting statement by the application deadline. Applications without a supporting statement cannot be considered.

    Travel visas
    Successful applicants will be provided with a support letter for their visa application, if required.

    Please visit the following websites for further information on visiting the UK:

  • Testimonials

    Feedback from the 2018 course:

    “A truly enriching experience! Would like to be back for more!”

    “Thank you very much for providing the platform for such courses to take place. It was better than I could have hoped for and I thoroughly enjoyed it. It solidified what was already known and built on top of that knowledge base so thank you.”

    “I would like to thank the organisers and the speakers very much for their effort and time in running this great course.”

    “Thank you very much for such a great course. I fell that my knowledge in drug discovery field grew up a lot during this week.”

    “I would like to thank everyone one of the course modulators for their work and sharing their experiences with us.”

    “Course content & organisation fantastic. Facilities amazing.”